(InSilico Medicine, Inc.) Insilico Medicine, a Rockville-based company developing the end-to-end drug discovery pipeline utilizing the next generation artificial intelligence, announces the presentation of Matt Kaeberlein, Ph.D., Department of Pathology, University of Washington, at 6th Aging Research, Drug Discovery, and AI Forum during the Basel Life Congress, Sept, 10-12, 2019, Basel, Switzerland.
from EurekAlert! - Technology, Engineering and Computer Science https://ift.tt/2O1yGjG
Tuesday, March 12, 2019
Dr. Matt Kaeberlein to present at the 6th Aging Research for Drug Discovery Forum Basel
About Admin -
Author Description here.. Nulla sagittis convallis. Curabitur consequat. Quisque metus enim, venenatis fermentum, mollis in, porta et, nibh. Duis vulputate elit in elit. Mauris dictum libero id justo.